Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease

(MedPage Today) — Adding ivonescimab to chemotherapy prolonged progression-free survival (PFS) in previously treated advanced EGFR-mutant non-small cell lung cancer (NSCLC), but failed to significantly improve overall survival (OS), the phase…

Source link : https://www.medpagetoday.com/meetingcoverage/iaslc/117380

Author :

Publish date : 2025-09-09 19:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease

‘Great Migration’ involves far fewer wildebeest than we had thought

CDC Autism Data Reviewed; Gabapentin Prescribing Concerns; Smoking and Parkinson’s

Related Posts

More children are obese than underweight, Unicef warns

Alzheimer’s blood test could ‘revolutionise’ diagnosis

RFK Jr.’s Latest MAHA Report Calls for More Scrutiny of Vaccines and Autism

RFK Jr. Has Declared Full-Blown War on CDC

Brain Iron Predicts Risk of Future Cognitive Impairment

CDC Infectious Disease Data Project Shelved

More children are obese than underweight, Unicef warns

Alzheimer’s blood test could ‘revolutionise’ diagnosis

RFK Jr.’s Latest MAHA Report Calls for More Scrutiny of Vaccines and Autism

RFK Jr. Has Declared Full-Blown War on CDC

Brain Iron Predicts Risk of Future Cognitive Impairment

CDC Infectious Disease Data Project Shelved

RFK Jr. May Link Vax Aluminum Adjuvant and Autism, Former FDA Chief Says

Physicians’ Group Recommends All Adults Get a COVID Booster

Categories

Archives